The A Adenosine Receptor (AAR) is an important therapeutic target due to its role in inflammation and immune response regulation. Herein, we synthesized and evaluated 5'-deoxy-adenosine derivatives with oxygen at the 4'-position, comparing them to previously studied 4'-thionucleosides. Compound exhibited the highest binding affinity ( = 5.9 ± 1.1 nM), consistent with the trend observed in the 4'-thionucleosides. Notably, the 5'-deoxy-adenosine derivatives demonstrated enhanced agonistic activity. Docking studies with compound revealed a shift in binding mode when oxygen replaced sulfur at the 4'-position. The compounds retained strong interactions with critical residues, such as Thr94, even without a hydrogen bond donor at the 5'-position. These results explain the increased agonistic effect observed when the ring heteroatom was changed from sulfur to oxygen.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726369 | PMC |
| http://dx.doi.org/10.1021/acsmedchemlett.4c00522 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis and Biological Evaluation of 5'-Deoxy-adenosine Derivatives as A Adenosine Receptor Ligands.
ACS Med Chem Lett
January 2025
Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea.
The A Adenosine Receptor (AAR) is an important therapeutic target due to its role in inflammation and immune response regulation. Herein, we synthesized and evaluated 5'-deoxy-adenosine derivatives with oxygen at the 4'-position, comparing them to previously studied 4'-thionucleosides. Compound exhibited the highest binding affinity ( = 5.
View Article and Find Full Text PDFInhibition of erythroblast growth and fetal hemoglobin production by ribofuranose-substituted adenosine derivatives.
Biochim Biophys Acta
September 2008
Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Laboratory Medicine Department, Hematology Service, National Institutes of Health, Bethesda, MD 20892, USA.
In vivo, inhibition of fetal hemoglobin (HbF) expression in humans around the time of birth causes the clinical manifestation of sickle cell and beta-thalassemia syndromes. Inhibition of HbF among cultured cells was recently described by the adenosine derivative molecule named SQ22536. Here, a primary cell culture model was utilized to further explore the inhibition of HbF by adenosine derivative molecules.
View Article and Find Full Text PDFAdenosine metabolism in the guinea pig heart: the role of cytosolic S-adenosyl-L-homocysteine hydrolase, 5'-nucleotidase and adenosine kinase.
Eur Heart J
November 1993
Physiologisches Institut, Heinrich Heine Universität, Düsseldorf, Germany.
This study was conducted to elucidate the role of S-adenosyl-L-homocysteine (SAH) hydrolase, 5'-nucleotidase and adenosine kinase in the production and removal of adenosine in the isolated guinea pig heart during normoxic (95% O2) and hypoxic (30% O2) perfusion. Using an adenosine kinase inhibitor (5'-amino-5'-deoxy-adenosine; 50 microM) and an adenosine deaminase inhibitor (EHNA; 5 microM) the total steady-state production rate of adenosine in the heart was estimated to be greater than 1.2 nmol.
View Article and Find Full Text PDFEffects of chronic 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxy- adenosine (AbeAdo) treatment on polyamine and eIF-5A metabolism in AbeAdo-sensitive and -resistant L1210 murine leukaemia cells.
Biochem J
February 1993
Department of Cellular and Molecular Physiology, M. S. Hershey Medical Center, Hershey, PA 17033.
We have previously reported that prolonged chronic exposure to the S-adenosyl-L-methionine decarboxylase (AdoMetDC) inhibitor, 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxy-adenosine (MDL 73811, AbeAdo), leads to cytostasis of L1210 cells [Byers, Ganem and Pegg (1992) Biochem. J. 287, 717-724].
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!